药物对比
Canagliflozin vs Pioglitazone
Canagliflozin（Invokana）与Pioglitazone（Actos）治疗糖尿病的比较。SGLT2抑制剂与噻唑烷二酮类：在血糖、体重、心脏健康及安全性方面哪种更好？
此页面暂无可用的对比维度。
临床背景
This comparison is triggered for type 2 diabetes patients needing add-on therapy after metformin, especially those with cardiovascular or kidney concerns versus marked insulin resistance.
结论
Canagliflozin is often preferred for its extra heart, kidney, and weight benefits, though Pioglitazone may suit select insulin-resistant patients without heart failure risk.
全部药物对比